Drug Profile
Research programme: serotonin 2A receptor agonists - Alcon
Alternative Names: AL-34659; Serotonin 2A receptor agonists research programme - AlconLatest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Class
- Mechanism of Action Serotonin 5-HT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glaucoma
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon
- 06 Apr 2006 This programme is still in active development
- 04 Sep 2005 Preclinical trials in Glaucoma in USA (Topical)